Pujun Gao

1.4k total citations
54 papers, 995 citations indexed

About

Pujun Gao is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Pujun Gao has authored 54 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 19 papers in Molecular Biology and 16 papers in Hepatology. Recurrent topics in Pujun Gao's work include Liver Disease Diagnosis and Treatment (25 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (7 papers). Pujun Gao is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (7 papers). Pujun Gao collaborates with scholars based in China, United States and Hong Kong. Pujun Gao's co-authors include Xu Li, Lili Ding, Hongqin Xu, Jiawen Han, Dong Wang, Junqi Niu, Qingfei Xiao, Ying Zhao, Liming Yang and Lina Zhou and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Pujun Gao

53 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pujun Gao China 19 355 298 225 138 136 54 995
Josepmaria Argemí Spain 19 421 1.2× 429 1.4× 229 1.0× 155 1.1× 145 1.1× 82 1.2k
Lu-Wen Wang China 19 267 0.8× 342 1.1× 156 0.7× 124 0.9× 58 0.4× 48 916
Marieke H. Schoemaker Netherlands 17 403 1.1× 367 1.2× 172 0.8× 85 0.6× 153 1.1× 29 1.3k
Keishi Kanno Japan 18 363 1.0× 359 1.2× 197 0.9× 70 0.5× 220 1.6× 64 1.1k
Man Li China 20 572 1.6× 532 1.8× 201 0.9× 226 1.6× 120 0.9× 106 1.7k
He-Sheng Luo China 17 270 0.8× 244 0.8× 104 0.5× 106 0.8× 203 1.5× 55 903
Xudong Feng China 19 205 0.6× 454 1.5× 96 0.4× 116 0.8× 135 1.0× 35 1.2k
Mevlüt Başkol Türkiye 17 291 0.8× 263 0.9× 143 0.6× 106 0.8× 143 1.1× 50 1.0k
Li Zhong China 17 278 0.8× 375 1.3× 121 0.5× 65 0.5× 94 0.7× 50 890
Ana Blas‐García Spain 25 543 1.5× 374 1.3× 225 1.0× 92 0.7× 92 0.7× 58 1.7k

Countries citing papers authored by Pujun Gao

Since Specialization
Citations

This map shows the geographic impact of Pujun Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pujun Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pujun Gao more than expected).

Fields of papers citing papers by Pujun Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pujun Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pujun Gao. The network helps show where Pujun Gao may publish in the future.

Co-authorship network of co-authors of Pujun Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Pujun Gao. A scholar is included among the top collaborators of Pujun Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pujun Gao. Pujun Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Shuang, Wenao Ma, Lin Mu, et al.. (2025). CT-based artificial intelligence system complementing deep learning model and radiologist for liver fibrosis staging. iScience. 28(4). 112224–112224.
2.
Ma, Zhanchuan, et al.. (2023). 5-HT induces regulatory B cells in fighting against inflammation-driven ulcerative colitis. International Immunopharmacology. 125(Pt A). 111042–111042. 9 indexed citations
3.
Wang, Shengnan, Hao Zhu, Lin Pan, et al.. (2023). Systemic inflammatory regulators and risk of acute-on-chronic liver failure: A bidirectional mendelian-randomization study. Frontiers in Cell and Developmental Biology. 11. 1125233–1125233. 51 indexed citations
4.
Li, Xu, Huifan Ji, Dezhi Zhang, et al.. (2022). Lymphoepithelioma‑Like Cholangiocarcinoma with Hepatitis C Virus Infection Treated by Microwave Ablation: A Literature Review and Case Report. Cancer Management and Research. Volume 14. 2155–2160. 3 indexed citations
5.
6.
Li, Xu, et al.. (2022). Case Report: Pediatric Hepatic Rhabdomyosarcoma With Maximum Lifetime. Frontiers in Medicine. 9. 858219–858219. 3 indexed citations
7.
Hou, Jie, Li Zhang, Hao Wu, Pujun Gao, & Zhonggao Xu. (2021). Increased Tim-3+ monocytes/macrophages are associated with disease severity in patients with IgA nephropathy. International Immunopharmacology. 97. 107666–107666. 5 indexed citations
8.
Wang, Luyuan, et al.. (2020). Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports. Journal of International Medical Research. 48(9). 1220761468–1220761468. 7 indexed citations
9.
Li, Xu, et al.. (2019). Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis. BioMed Research International. 2019. 1–8. 41 indexed citations
10.
11.
Li, Xu, Pujun Gao, & Junqi Niu. (2019). Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. BioMed Research International. 2019. 1–9. 8 indexed citations
12.
Gao, Pujun, et al.. (2018). Hepatitis C Virus Infection Increases Risk of Gallstone Disease in Elderly Chinese Patients with Chronic Liver Disease. Scientific Reports. 8(1). 4636–4636. 11 indexed citations
13.
Hou, Jie, Manli Zhang, Xinrui Wang, et al.. (2018). Circulating CD14+CD163+CD206+ M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy. Mediators of Inflammation. 2018. 1–10. 25 indexed citations
14.
Xiao, Qingfei, Zhihui Qu, Ying Zhao, Liming Yang, & Pujun Gao. (2017). Orientin Ameliorates LPS‐Induced Inflammatory Responses through the Inhibitory of the NF‐κB Pathway and NLRP3 Inflammasome. Evidence-based Complementary and Alternative Medicine. 2017(1). 2495496–2495496. 43 indexed citations
15.
Li, Xu, et al.. (2017). Diabetes Mellitus and Risk of Hepatocellular Carcinoma. BioMed Research International. 2017. 1–10. 60 indexed citations
16.
Li, Xu, Yang Gao, Hongqin Xu, Jie Hou, & Pujun Gao. (2017). Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients. Scientific Reports. 7(1). 9087–9087. 19 indexed citations
17.
Li, Xu, et al.. (2017). Gallstones in Patients with Chronic Liver Diseases. BioMed Research International. 2017. 1–8. 23 indexed citations
18.
Zhang, Nannan, Haoran Guo, Guanchen Liu, et al.. (2017). The poly-proline tail of SIVmac Vpx provides gain of function for resistance to a cryptic proteasome-dependent degradation pathway. Virology. 511. 23–29. 1 indexed citations
19.
Li, Xu, Qinglong Jin, Hongqin Xu, et al.. (2017). Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment. Experimental and Therapeutic Medicine. 13(6). 3624–3630. 2 indexed citations
20.
Liu, Yaming & Pujun Gao. (2014). Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virus-producing hepatoma cells. Molecular Medicine Reports. 10(6). 3113–3117. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026